INTRODUCTION
Tracheal extubation is associated with acute, transient, significant and undesirable haemodynamic and airway responses that may persist into the recovery period. Stimulation of the respiratory tract at the supraglottic and subglottic levels and an increase in the release of circulatory catecholamines produce these responses. [1] The reflexes ranges from tachycardia, hypertension, Journal of Neuroanaesthesiology and Critical Care | Vol. 3 • Issue 1 • Jan-Apr 2016 | combined α-β blocker like labetalol; [8] Ca 2+ channel blockers like diltiazem, [9] verapamil, [10] nicardipine; [11] intravenous lignocaine, [12] lidocaine spray, [13] intracuff lignocaine; [14] low dose iv opioids like fentanyl, [15] remifentanil, [16] alfentanil, [17] sufentanil; [18] central sympatholytics like clonidine, [19] dexmedetomidine; [20] vasodilators like nitrates, [21] prostaglandin [22] and MgSO 4 [23] have been studied as sole agent or in comparison with each other to control haemodynamic changes and upper airway tract events with variable success rates.
Rapid and smooth emergence after general anaesthesia in spinal surgery is desirable to allow early neurological examination. Till date, no study in literature has compared the effects of verapamil and dexmedetomidine for attenuation of extubation reflexes. In the present study, we have attempted to evaluate and compare the efficacy of intravenous verapamil (phenylalkylamine group of calcium channel blocker) and dexmedetomidine (α 2 -adrenoceptor agonist) on attenuation of airway and haemodynamic responses following tracheal extubation in patients undergoing elective spinal surgery under general anaesthesia.
MATERIALS AND METHODS
This study was conducted in the department of Anaesthesioloy in Neurosurgery Operation Theatre at Tertiary Care Centre. This prospective, randomised, double-blind study included 30 patients of American Society of Anesthesiologists Grade I and II, age 20-50 years, body weight 50-70 kg who underwent spinal surgeries in the elective theater. Prior ethical permission was taken from our Institutional Ethical Committee and Review Board and written informed consent was obtained from all patients enrolled for the study.
Patients with history of respiratory, cardiac, hepatic, renal or metabolic disorder, convulsion, allergy to the drug used, bleeding disorder, severe neurological deficit or low Glasgow Coma Scale (GCS) score, chronic alcohol or drug abuse, patients being treated with drugs like adrenoceptor agonist or antagonist, digoxin, anticonvulsants or psychotropic medications, pregnant or lactating mother, patients with bradycardia, hypertension, severe hypovolemia were excluded from the study. Other exclusion criteria included patients with suspicious difficult intubation or who required multiple attempts for intubation and those who required postoperative mechanical ventilation.
The patients were randomized on the day of surgery into two groups each of 15 patients by chit in box method. Medications were prepared and hidden behind drapes and administered by one anaesthesiologist, and observations were made by another anaesthesiologist who was blinded to the group to which the patient was assigned. In Group V, 15 patients received 0.1 mg/kg verapamil and in Group D, 15 patients received 0.3 mcg/kg dexmedetomidine. All the drugs were prepared in identical syringes diluted with isotonic normal saline to make a total volume of 10 ml.
Patients were kept nil per oral from midnight before surgery. After shifting the patient to the elective operation theater, two large bore (18 G) intravenous access were obtained, and Ringer lactate was started at the rate of 10 ml/kg/h. Preinduction monitors like pulse oximeter, noninvasive blood pressure, 5-lead electrocardiogram were connected and heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), SpO 2 were recorded at this time. Patients were premedicated with intravenous midazolam (0.02 mg/kg), glycopyrrolate (0.005 mg/kg) and fentanyl (2 mcg/kg). After preoxygenation for 3 min, general anaesthesia was induced with inj. thiopental sodium 5 mg/kg followed by inj. rocuronium 1 mg/ kg was given to facilitate direct laryngoscopy and orotracheal intubation (high-volume/low-pressure cuffed endotracheal tubes). The internal diameter of the endotracheal tube was 7-7.5 mm for women and 8-8.5 mm for men. All the patients were mechanically ventilated at a fresh gas flow of 4 L/min and anaesthesia was maintained with sevoflurane in nitrous oxide and oxygen (60:40) (minimum alveolar concentration 0.8-1.0) and vecuronium (0.02 mg/kg every 30-40 min) throughout the surgical procedure. Intraoperative analgesia was supplemented with incremental doses of fentanyl every hour. Intraoperatively EtCO 2 , bispectral index (BIS), temperature, and urine output were also monitored. During mechanical ventilation, a respiratory rate of 12-16/min and tidal volume of 8-10 ml/kg were used, which were adjusted to keep normocapnia and normoxia with oxygen saturation ≥ 98%. Ringer lactate and normal saline were used for replacement and maintenance. Colloids, blood and blood products were used if required.
At the end of surgery, all anesthetic agents were discontinued, and patients were ventilated with 100% oxygen. After dressing of the surgical wound, the patient was turned supine. On the return of spontaneous efforts (BIS > 80), study drugs were administered over 60 s. Neuromuscular blockade was reversed with neostigmine 0.05 mg/kg and glycopyrrolate 0.01 mg/kg. Oropharyngeal secretions were gently aspirated by suction catheter. Once patient became conscious and responded to verbal commands extubation was performed. After extubation, the patients were oxygenated with 100% oxygen for 5 min. The values for HR, SBP, DBP and MAP were obtained just before administration of the study drug (baseline value, T 0 ), 2 min after the injection of study medications (T M ), just after oral suction (T S ), immediately after extubation (T E ) and 1, 3, 5 and 10 min postextubation (E 1 , E 3 , E 5 , E 10 ) and compared among the two groups. Duration of emergence and extubation were also compared.
The quality of extubation was assessed with a five-point scale, [24] where (1) no cough, smooth extubation, (2) smooth extubation, minimal coughing (1-2 times), (3) moderate coughing (3 or 4 times), (4) severe coughing (5 to 10 times) and difficulty in breathing, (5) poor extubation, very uncomfortable and forced breathing (laryngospasm and coughing >10 times). After extubation, all these patients were also observed for sedation by Richmond Agitation Sedation Score (RASS). [25] Time to reach modified Aldrete Score ≥9 from the termination of anaesthesia was noted for early shifting of patients from recovery unit to the neurosurgical ward for supportive care.
We defined following terms for the study:
• Hypotension = SBP < 20% of baseline value or 90 mmHg or MAP < 60 mmHg whichever is lower • Hypertension = SBP > 20% of baseline value or 150 mmHg, whichever is higher • Tachycardia = HR > 25% of baseline value.
• Bradycardia = HR < 60 bpm.
Emergence time = the time interval between discontinuing of anesthetic agents and patient following verbal commands.
Extubation time = the time interval between cessation of anesthetic agents and tracheal extubation.
Various complications such as desaturation, breath holding, laryngospasm, bronchospasm, bradycardia, hypotension, nausea, vomiting, restlessness, etc., were also noted.
Statistical analysis
The sample size was calculated 15 subjects in each group with alpha error 0.05 and power 80%, based on a pilot study on 10 patients, with the quality of extubation (extubation score) as the primary outcome. Sample size was calculated by Primer of Biostatistics software version 6.0 (by Stanton A. Glantz, © 2005 McGraw-Hill) and analysis of the statistical data obtained from study was carried out by Statistical Package for the Social Sciences software version 21 (SPSS Inc., Chicago, Illinois, USA). The categorical measurements were summarized as the number and percentage, continuous measurements as the arithmetic mean and standard deviation. The numerical data were analyzed using Student's t-test. Corresponding 'P' values were also calculated. Statistical significance was accepted as not significant and significant at P > 0.05 and P < 0.05, respectively. Statistical significance of extubation scores was obtained using Mann-Whitney U-test.
RESULTS
A total of 30 patients were included in this randomized, double-blind trial, and none excluded from final analysis. No statistical differences were found with respect to age, sex, weight, preinduction and baseline HR, SBP, DBP, and MAP between the two groups [ Tables 1 and 2 ].
In Group D, a statistically significant (P < 0.05) decrease in HR was observed up to E 10 stage, whereas in Group V, at these stages changes were statistically insignificant (P > 0.05) [ Figure 1 ]. In intergroup comparison, these changes were statistically insignificant (P > 0.05). Bradycardia occurred in one patient within 2 min of drug administration in Group D.
The MAP between the two groups showed the statistically significant difference (P < 0.05) at stage T M and E 10 . Immediately after suction (T S ), MAP was low in Group D compared to T 0 stage and Group V, but statistically insignificant (P > 0.05). Immediately after extubation (T E ), there was an increase in MAP in both the groups but statistically insignificant (P > 0.05) [ Figure 2 ].
None of the patient required any medical intervention for fluctuation in haemodynamic parameters.
Extubation quality score was noted at the time of extubation. 80% of the patients in Group D could be RASS score was in the range of −1 to +1 in >90% patient in Group V whereas −3 to −1 in 80% cases in Group D [ Figure 4 ]. So, a higher degree of sedation was noted in Group D whereas in Group V most of the patients were anxious and agitated or restless.
There was no statistically significant difference between the duration of surgery and duration of anaesthesia between the two groups. Mean emergence and extubation times were slightly higher in Group D but not statistically significant (P = 0.228 and P = 0.075). The median time to reach Modified Aldrete score ≥9 was also statistically insignificant between the two groups [ Table 3 ].
DISCUSSION
Anaesthesiologists are most worried about problems associated with extubation, recovery and emergence as these are more common than problems at intubation and many aspects are controversial with no clear guidelines or protocols. Tracheal extubation is associated with a 10-30% increase in arterial pressure and HR lasting 5-15 min. Respiratory complications after tracheal extubation are 3 times more common than complications occurring during tracheal intubation and induction of anaesthesia (4.6% vs. 12.6%). [26] Hence, we decided to do a comparative study on alleviation of this response with pharmacological agents.
The main findings of our study are as follows:
• The HR was maintained below the baseline value in Group D but increased in Group V immediately after suction and extubation. Only one patient had bradycardia in Group D • The SBP, DBP, MAP were increased above the baseline, but dexmedetomidine attenuated the increase in blood pressure (BP) better than verapamil • The airway response was better attenuated with dexmedetomidine than with verapamil • A higher degree of sedation was noted in dexmedetomidine group • No difference in median time to achieve required Aldrete score in between two groups.
Different studies in the literature have recommended the use of verapamil to control circulatory responses occurring during extubation. However, intravenous verapamil has short onset of action of about 30 s, peak action in 2-3 min, brief duration of action due to rapid redistribution, that is, up to 10 min, excellent negative chronotropic and negative inotropic effect. Jajoo et al. studied two different doses of verapamil and suggested that a bolus injection of verapamil 0.1 mg/kg given 2 min before tracheal extubation is a more effective prophylactic for attenuating the cardiovascular changes associated with extubation than 0.05 mg/kg dose. [10] Mikawa et al. compared the effect of intravenous injection of verapamil and diltiazem and concluded that a bolus injection of verapamil 0.1 mg/kg is a more effective than is diltiazem 0.2 mg/kg in attenuation of cardiovascular response. [27] Mikawa et al. in another study concluded that a combination of verapamil 0.1 mg/kg and lidocaine 1 mg/kg is superior to each drug alone for suppressing the hypertensive and tachycardic responses to tracheal extubation. [28] Hence, we used verapamil 0.1 mg/kg in our study.
Dexmedetomidine is a highly selective α 2 agonist, which has potent sedative, anxiolytic and analgesic activity. It activates receptors in the medullary vasomotor center, reducing norepinephrine turnover and decreasing central sympathetic outflow, resulting in alterations in sympathetic function and decreased HR and BP. In our study, there was lesser rise in HR and MAP during suction (T S ) and extubation (T E ) in Group D compared to Group V which could be due to dexmedetomidine induced sedation, analgesia and decreased catecholamine levels, inhibition of central sympathetic outflow and enhanced vagal activity.
The degree of haemodynamic effects depends on the dose and fluid status of the patient. In the peripheral blood vessels, direct action on α 2B receptors produces vasoconstriction, which may lead to hypertension. Sharma et al. studied the effect of bolus administration of dexmedetomidine 0.5 mcg/kg over 60 s in patients undergoing spinal surgeries and observed increase in MAPs in the first 2 min after drug administration, which returned to normal values after 3 min. [29] We did not experience such transient hypertension in our study with the dose of 0.3 mcg/kg.
The activation of α 2 adrenoceptors especially in the nucleus tractus solitarius by dexmedetomidine causes bradycardia. Bindu et al. studied the effect of intravenous dexmedetomidine infusion 0.75 mcg/kg given 15 min prior to extubation and concluded that dexmedetomidine stabilises haemodynamic and facilitates smooth extubation, but there was bradycardia in 13 patients out of 25 patients. [30] Aksu et al. compare the effects of dexmedetomidine (0.5 mcg/kg) and fentanyl (1 mcg/kg) in patients undergoing rhinoplasty and concluded that dexmedetomidine was more effective in attenuating airway reflex responses to tracheal extubation and maintaining haemodynamic stability compared to fentanyl but was associated with bradycardia in two patients out of 20 patients. [31] Guler et al. studied the effect of a single bolus dose of dexmedetomidine (0.5 µg/kg) intravenously over 60 s in patients undergoing intraocular surgery and experienced bradycardia in one patient and hypotension in three patients out of 30 patients. [24] Ali and Abdellatif compared the effect of a single dose of dexmedetomidine (0.3 µg/kg) and propofol (1 mg/kg) administered prior to termination of sevoflurane-based anaesthesia on the incidence and severity of emergence agitation in children and found that dexmedetomidine was more effective than propofol without any incidence of bradycardia. [32] We used dexmedetomidine in a low dose (0.3 µg/kg) and observed bradycardia in one patient, but no incidence of hypotension.
In vitro studies indicate that α 2 receptor stimulation can cause smooth muscle relaxation thereby preventing bronchoconstriction. [29] In our study, there was decrease incidence of cough in dexmedetomidine group during extubation.
The sedative and anxiolytic effects of dexmedetomidine result primarily from its activity in the locus coeruleus of the brain stem. Riessen et al. investigated the newly introduced RASS for better monitoring of sedation depth and concluded that, in routine use Ramsay score showed a poor performance than RASS regarding the measurement of sedation depth. [25] Hence, we used RASS score in our study and found that most patients in Group D were drowsy, that is, not fully alert but has sustained awakening to voice (RAAS-1) after extubation whereas in Group V, most patients belonged to RAAS + 1.
In our study, none of the patients in either group developed respiratory depression, laryngospasm or bronchospasm.
In our study, we did not measure the plasma norepinephrine levels, which could precisely predict the suppression of the sympathetic response to extubation.
CONCLUSION
We concluded that, dexmedetomidine is more effective in attenuation of extubation responses in terms of better extubation score and better haemodynamic control compared with verapamil except that it can cause bradycardia and more sedation in neurosurgical patients. However caution to be observed in patients with preexisting bradycardia or low GCS.
